ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Sangamo Therapeutics Inc

Sangamo Therapeutics Inc (GBY)

1.1622
0.0306
( 2.70% )
Actualizado: 14:36:44
Realtime Data

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
1.1622
Postura de Compra
1.15
Postura de Venta
1.1712
Volume Operado de la Acción
12,460
1.1168 Rango del Día 1.1622
0.2901 Rango de 52 semanas 3.3005
Capitalización de Mercado [m]
Precio Anterior
1.1316
Precio de Apertura
1.1168
Última hora de negociación
09:18:16
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
58,098
Acciones en circulación
208,646,870
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.99
Beneficio por acción (BPA)
-1.24
turnover
176.23M
Beneficio neto
-257.83M

Acerca de Sangamo Therapeutics Inc

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Sangamo Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker GBY. The last closing price for Sangamo Therapeutics was 1.13 €. Over the last year, Sangamo Therapeutics shares have traded in a share price range of 0.2901 € to 3.3005 €.

Sangamo Therapeutics currently has 208,646,870 shares in issue. The market capitalisation of Sangamo Therapeutics is 236.10 € million. Sangamo Therapeutics has a price to earnings ratio (PE ratio) of -0.99.

GBY Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.05865.30989537061.10359991.2381.0593961.13041069DE
4-0.1694-12.72153895481.33159991.4350.9501376451.1403801DE
12-1.4128001-54.8660233012.5753.30050.9425580981.81179826DE
260.397099951.90169912430.76513.30050.6304999551261.50913347DE
520.6897999146.0203005930.47243.30050.2901428861.21332099DE
156-3.6898001-76.04699299264.8525.70.2722250901.1680831DE
260-5.6338001-82.89876545036.79615.6680.2722130091.513568DE

GBY - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Sangamo Therapeutics?
El precio actual de las acciones de Sangamo Therapeutics es 1.1622 €
¿Cuántas acciones de Sangamo Therapeutics están en circulación?
Sangamo Therapeutics tiene 208,646,870 acciones en circulación
¿Cuál es la capitalización de mercado de Sangamo Therapeutics?
La capitalización de mercado de Sangamo Therapeutics es EUR 236.1M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Sangamo Therapeutics?
Sangamo Therapeutics ha negociado en un rango de 0.2901 € a 3.3005 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Sangamo Therapeutics?
El ratio precio/beneficio de Sangamo Therapeutics es -0.99
¿Cuál es el ratio de efectivo a ventas de Sangamo Therapeutics?
El ratio de efectivo a ventas de Sangamo Therapeutics es 1.44
¿Cuál es la moneda de reporte de Sangamo Therapeutics?
Sangamo Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Sangamo Therapeutics?
El último ingresos anual de Sangamo Therapeutics es USD 176.23M
¿Cuál es el último beneficio anual de Sangamo Therapeutics?
El último beneficio anual de Sangamo Therapeutics es USD -257.83M
¿Cuál es la dirección registrada de Sangamo Therapeutics?
La dirección registrada de Sangamo Therapeutics es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Sangamo Therapeutics?
La dirección del sitio web de Sangamo Therapeutics es www.sangamo.com
¿En qué sector industrial opera Sangamo Therapeutics?
Sangamo Therapeutics opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
7S8SITC International Holdings Company Limited
42.31 €
(1,772.12%)
1.31k
0K91Quantum BioPharma Ltd
6.45 €
(110.78%)
21.85k
WDL1Nakiki SE
0.50 €
(42.05%)
4.84k
1SSNextech3d Ai Corp
0.045 €
(41.51%)
360.19k
NL8Genesis Ai Corp
0.0248 €
(33.33%)
5k
E3O1Nexoptic Technology Corp
0.008 €
(-48.39%)
417
1RR1Rokmaster Resources Corp
0.007 €
(-41.67%)
1.23k
TH92Embracer Group AB
12.00 €
(-40.09%)
18.13k
Y92Trilogy AI Corp
0.0935 €
(-38.08%)
1.98k
4APApollo Minerals Ltd
0.005 €
(-37.50%)
80k
VODIVodafone Group plc
0.792 €
(-3.70%)
4.64M
3CPXiaomi Corporation
4.9625 €
(3.07%)
2.04M
D7GNel ASA
0.1941 €
(0.88%)
2.02M
G7PAEnergy Transition Minerals Ltd
0.0494 €
(19.90%)
1.59M
76M0Realbotix Corp
0.332 €
(0.61%)
1.38M
Trooperstocks Trooperstocks 2 minutos hace
$ONAR Onar Holdings Corp New TICKER! ONAR's CEO Claude Zdanow presented insights at The Microcap Conference which was held January 28-30, 2025. The company's AI-driven approach and acquisition strategy is to procure more specialized agencies in 2025, while continuing to deliver unmatched service an
ONAR
boston127 boston127 2 minutos hace
I had a strong sense that something

good was finally happening here. It was stable. Volume was good. No dips into the 3s.
IGPK
Stevenvegas Stevenvegas 3 minutos hace
9 and 7 cases.... per million. It's not a hard side to take
PFE
Trooperstocks Trooperstocks 3 minutos hace
$ONAR Onar Holdings Corp New TICKER! ONAR's CEO Claude Zdanow presented insights at The Microcap Conference which was held January 28-30, 2025. The company's AI-driven approach and acquisition strategy is to procure more specialized agencies in 2025, while continuing to deliver unmatched service an
ONAR
Invest-in-America Invest-in-America 3 minutos hace
QNTM: Impossible!!
QNTM
Gmenfan Gmenfan 3 minutos hace
Isn't it strange how the tough guy liberals backpedal when called out!?
Jetmek_03052 Jetmek_03052 3 minutos hace
Indeed. How many “deadlines” has everyone suffered through, only to see NOTHING HAPPEN??

Don’t these fools realize that it’s only a matter of time before they’re proven wrong AGAIN?!

In two weeks, that deadline will arrive and then go by - with NOTHING happening to the
DBMM
vlispxpert vlispxpert 4 minutos hace
QXO said many times, IF they get buyout, this is $100+ stock...longshot as BECN trying to resist the takeover...but price action saying something may be cooking..imo
TenKay TenKay 4 minutos hace
Oh he and I had a lot of back and forth on TDEY.
HMBL
jimmybob jimmybob 4 minutos hace
Afternoon Rant if you missed -> https://www.optionmillionaires.com/jb-afternoon-rant-2-5-2025/
zab zab 4 minutos hace
https://www.msn.com/en-us/news/politics/unhinged-trump-white-house-and-gop-in-full-meltdown-over-hakeem-jeffries-fight-in-the-streets-comment-while-democrats-dismiss-demand-for-apology-calling-it-laughable/ar-AA1ylUOf?ocid=msedgntp&pc=U531&cvid=6e2d453eb982416ab4785380f1362405&ei=12

o
Mr.Joness Mr.Joness 4 minutos hace
Stop me if you've heard this one before.
SANP
trader_ron trader_ron 4 minutos hace
style="caret-color: rgb(0, 0, 0); color: rgba(0, 0, 0, 1); font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, Helvetica, sans-serif; white-space: pre-wrap; background-color: rgba(255, 255, 255, 1)"$MNMRF - Globe Small Cap Research covers Monumental Energy Corp. (OTCQB: $MNMRF) US
MNMRF
money-maker money-maker 4 minutos hace
Till end of the month sounds promising... 
VGTL
Jimmy Joe Jimmy Joe 4 minutos hace
There are no FTD’s and the DTCC share count matches the OS share count reported by the company.


Who is the DTCC~? The banks, market makers, and broker/dealers are the DTCC. Who sits on the BoDs of the DTCC and FINRA~?
"They" sit on the BoD of the DTCC and FINRA. No conf
DBMM
misterfishman misterfishman 5 minutos hace
wow bro its been a long time since we saw 5
IGPK
rbl100 rbl100 5 minutos hace
I still don't have my one share.
ACON
Invest-in-America Invest-in-America 5 minutos hace
I like BOTH, Boss!!! (And right now, shockingly scoring nicely on my @QNTM --- poorly executed --- gambit today!! Can NOT believe that QNTM came back off the mat!!)
QNTM
valleybenedetto valleybenedetto 5 minutos hace
I wouldn't hold a stock that I had such disregard for. I buy and sell all day , gold what I like sell what I don't. Why are you still holding of you think so little of what we're doing? Genuine question. 
CLNV
SC8 SC8 5 minutos hace
So Radiogel does nothing for 5 doomed patients, doesn't even kill the treated tumors, but somehow that confirms Radiogel safety? The delusions here know no bounds.
RDGL
Prudent Capitalist Prudent Capitalist 5 minutos hace
Correct. We have a long way to go to get back to reasonable valuations, but things are headed in a better direction. NB shares were way too oversold and got hit pretty hard during tax loss selling season late last year.
NB
esi23 esi23 5 minutos hace
Like it.  Tripled up on 038.  Nils will come through this time.    $$$$$
BMXI
zab zab 5 minutos hace
https://www.yahoo.com/news/trump-set-reimpose-maximum-pressure-162302281.html

It appears each day trump wants to start a fight with everyone, so much for his promise to end the current war in Ukraine.
linkvest linkvest 6 minutos hace
When the News hits that will open the flood gates of the 4s to see who gets to the 6s and 7s before they are gone.
ASII
Slim_Jim Slim_Jim 6 minutos hace
Guessing a 10-K/Annual out sometime this month.
LWLG

Su Consulta Reciente

Delayed Upgrade Clock